Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

PBYI

Puma Biotechnology Inc

Dec 12 • 04:00PM ET

2.92

Dollar change -0.02
Percentage change -0.68	%

Healthcare • Biotechnology • USA • NASD

Peers: INCY MRNA EXEL SRPT BPMC FGEN NKTR KPTI LGND AFMD

| Held by: VTI IWM AVUV VXF IWN VTWO DFAS IWO IWC FESM

Scroll to Statements

Index	RUT	P/E	6.15	EPS (ttm)	0.47	Insider Own	28.99%	Shs Outstand	49.07M	Perf Week	-4.89%
Market Cap	143.34M	Forward P/E	8.59	EPS next Y	0.34	Insider Trans	-1.30%	Shs Float	34.86M	Perf Month	-9.03%
Income	23.24M	PEG	-	EPS next Q	0.09	Inst Own	54.36%	Short Float	8.05%	Perf Quarter	15.42%
Sales	243.57M	P/S	0.59	EPS this Y	-33.33%	Inst Trans	-3.86%	Short Ratio	7.11	Perf Half Y	-12.05%
Book/sh	1.45	P/B	2.02	EPS next Y	13.33%	ROA	10.95%	Short Interest	2.81M	Perf Year	-22.13%
Cash/sh	1.97	P/C	1.48	EPS next 5Y	-	ROE	42.32%	52W Range	2.22 - 7.73	Perf YTD	-32.56%
Dividend Est.	-	P/FCF	4.26	EPS past 5Y	-	ROI	21.76%	52W High	-62.23%	Beta	1.09
Dividend TTM	-	Quick Ratio	1.40	Sales past 5Y	-0.59%	Gross Margin	69.29%	52W Low	31.24%	ATR (14)	0.23
Dividend Ex-Date	-	Current Ratio	1.42	EPS Y/Y TTM	537.28%	Oper. Margin	13.30%	RSI (14)	47.09	Volatility	6.96% 8.75%
Employees	185	Debt/Eq	1.21	Sales Y/Y TTM	6.30%	Profit Margin	9.54%	Recom	3.00	Target Price	4.33
Option/Short	Yes / Yes	LT Debt/Eq	0.50	EPS Q/Q	240.92%	Payout	0.00%	Rel Volume	1.14	Prev Close	2.94
Sales Surprise	13.94%	EPS Surprise	23.01%	Sales Q/Q	43.53%	Earnings	Nov 07 AMC	Avg Volume	394.52K	Price	2.92
SMA20	-2.72%	SMA50	0.13%	SMA200	-20.35%	Trades		Volume	450,665	Change	-0.68%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-28-21	Upgrade	Citigroup	Neutral → Buy	$11
Jun-25-20	Resumed	BofA/Merrill	Underperform	$9
Oct-08-19	Downgrade	Goldman	Neutral → Sell	$24 → $8
May-10-19	Downgrade	Citigroup	Buy → Neutral	$24
May-10-19	Downgrade	Cantor Fitzgerald	Overweight → Neutral	$57 → $20
Jan-17-19	Initiated	Leerink Partners	Mkt Perform	$21
Jan-03-19	Downgrade	Guggenheim	Buy → Neutral
Nov-19-18	Upgrade	Goldman	Sell → Neutral
Nov-02-18	Downgrade	JP Morgan	Neutral → Underweight
Nov-02-18	Downgrade	BofA/Merrill	Buy → Underperform
Oct-01-18	Initiated	Cantor Fitzgerald	Overweight	$75
Sep-17-18	Initiated	Goldman	Sell	$42
May-11-18	Reiterated	Stifel	Buy	$95 → $87
Nov-10-17	Reiterated	RBC Capital Mkts	Sector Perform	$92 → $108
Nov-10-17	Reiterated	Citigroup	Buy	$156 → $164
Oct-02-17	Reiterated	Stifel	Buy	$110 → $130
Sep-11-17	Reiterated	Credit Suisse	Outperform	$118 → $136
Jul-10-17	Resumed	Leerink Partners	Outperform	$115
Jun-06-17	Reiterated	RBC Capital Mkts	Sector Perform	$60 → $88
May-25-17	Reiterated	RBC Capital Mkts	Sector Perform	$40 → $60

Show Previous Ratings

Dec-04-24 05:15PM	Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Nov-28-24 09:40AM	Should Value Investors Buy Puma Biotechnology (PBYI) Stock? (Zacks)
Nov-21-24 05:38AM	Puma commences Phase II trial of alisertib for breast cancer treatment (Clinical Trials Arena)
Nov-20-24 08:57AM	Puma Biotechnology Announces Initiation of ALISCA-Breast1 Phase II Trial of Alisertib in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer (Business Wire)
Nov-08-24 02:27AM	Puma Biotechnology Inc (PBYI) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic ... (GuruFocus.com)
05:33PM	Loading…
Nov-07-24 05:33PM	Puma Biotech: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Puma Biotechnology Reports Third Quarter 2024 Financial Results (Business Wire)
Nov-05-24 05:15PM	Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Oct-24-24 04:07PM	Puma Biotechnology to Host Conference Call to Discuss Third Quarter Financial Results (Business Wire) +5.36%
Sep-12-24 07:59AM	Transforming Cancer Therapy Stocks to Watch In The Oncology Sector (News Direct)
Sep-03-24 04:15PM	Puma Biotechnology to Present at the H.C. Wainwright 26th Annual Global Investment Conference (Business Wire)
Aug-21-24 05:00AM	The Future of Medicine: Key Biotech Stocks to Watch (News Direct)
Aug-06-24 05:23PM	Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) +12.26% -7.44%
Aug-02-24 10:07AM	Puma Biotechnology's (PBYI) Q2 Loss Narrower Than Expected (Zacks) +9.43%
Aug-01-24 05:04PM	Puma Biotech: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Loading…
04:05PM	Puma Biotechnology Reports Second Quarter Financial Results (Business Wire)
Jul-23-24 09:40AM	Should Value Investors Buy Puma Biotechnology (PBYI) Stock? (Zacks)
Jul-18-24 04:10PM	Puma Biotechnology to Host Conference Call to Discuss Second Quarter 2024 Financial Results (Business Wire)
Jul-02-24 05:30PM	Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) -5.49%
Jun-07-24 05:37PM	Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Jun-03-24 02:33PM	Puma Biotechnology Announces Presentation of Findings from a Phase I/Ib Study of Alisertib in Advanced EGFR-Mutated Lung Cancer (Business Wire)
Jun-02-24 10:01AM	Puma Biotechnology Announces Presentation of Findings from a Phase II Study of Alisertib in Endocrine-Resistant Metastatic Breast Cancer (TBCRC 041) (Business Wire)
May-28-24 09:00AM	Puma Biotechnology to Join Russell 3000 Index (Business Wire)
May-24-24 11:57AM	Puma Biotechnology (PBYI) Falls 38% in 3 Months: Here's Why (Zacks)
May-23-24 05:15PM	Puma Biotechnology Announces Publication of Alisertib Abstract Titles for the 2024 ASCO Annual Meeting (Business Wire) -5.67%
May-20-24 09:59AM	Implied Volatility Surging for Puma Biotechnology (PBYI) Stock Options (Zacks) +6.72%
May-03-24 01:09PM	Puma Biotechnology, Inc. (NASDAQ:PBYI) Q1 2024 Earnings Call Transcript (Insider Monkey)
11:31AM	Puma Biotechnology's (PBYI) Q1 Earnings and Revenues Beat (Zacks)
04:02AM	Puma Biotechnology Inc (PBYI) Q1 2024 Earnings Call Transcript Highlights: A Detailed Review of ... (GuruFocus.com)
May-02-24 09:55PM	PBYI Stock Earnings: Puma Biotechnology Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
06:05PM	Loading…
06:05PM	Puma Biotech (PBYI) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
05:48PM	Puma Biotechnology Inc (PBYI) Reports Q1 Financial Results, Misses Analyst Revenue and EPS Forecasts (GuruFocus.com)
05:12PM	Puma Biotech: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Puma Biotechnology Reports First Quarter Financial Results (Business Wire)
Apr-26-24 11:40AM	What's in Store for Puma Biotechnology (PBYI) in Q1 Earnings? (Zacks)
Apr-25-24 10:02AM	Earnings Preview: Puma Biotech (PBYI) Q1 Earnings Expected to Decline (Zacks)
Apr-18-24 04:15PM	Puma Biotechnology to Host Conference Call to Discuss First Quarter 2024 Financial Results (Business Wire)
Apr-11-24 06:00PM	Puma Biotech (PBYI) Stock Dips While Market Gains: Key Facts (Zacks)
Apr-03-24 05:30PM	Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Mar-22-24 09:25AM	Puma Biotechnology (PBYI) Soars 14.0%: Is Further Upside Left in the Stock? (Zacks)
Mar-20-24 08:30AM	Puma Biotechnology Announces FDA Allowance to Proceed Under IND for Alisertib in HER2-Negative, Hormone Receptor-Positive Metastatic Breast Cancer (Business Wire) +9.19%
Mar-02-24 08:29AM	Puma Biotechnology, Inc. (NASDAQ:PBYI) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-01-24 09:55AM	Q4 2023 Puma Biotechnology Inc Earnings Call (Thomson Reuters StreetEvents) -5.31%
09:40AM	Why Puma Biotech (PBYI) is a Top Value Stock for the Long-Term (Zacks)
09:39AM	Puma Biotechnology (PBYI) Q4 Earnings & Revenues Lag Estimates (Zacks)
Feb-29-24 04:41PM	Puma Biotechnology Inc (PBYI) Reports Positive Net Income for Q4 and Full Year 2023 (GuruFocus.com) -5.76%
04:40PM	Puma Biotech: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Puma Biotechnology Reports Fourth Quarter and Full Year 2023 Financial Results (Business Wire)
Feb-27-24 06:30PM	Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
11:51AM	Puma Biotechnology (PBYI) to Report Q4 Earnings: What's in Store? (Zacks)
Feb-22-24 04:10PM	Puma Biotechnology to Participate in a Panel Discussion at TD Cowens 44th Annual Health Care Conference (Business Wire) -9.22% +10.83%
Feb-15-24 04:10PM	Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results (Business Wire) -5.54%
Feb-13-24 08:30AM	Puma Biotechnology Announces Initiation of ALISCA-Lung1 Phase II Trial of Alisertib in Small Cell Lung Cancer (Business Wire)
Jan-31-24 12:58PM	3 Strong Buy Stocks Under $5: January 2024 (InvestorPlace)
Jan-11-24 04:07PM	Puma Biotechnology to Present at B. Riley Securities 4th Annual Oncology Conference (Business Wire) +8.44%
Jan-06-24 11:02AM	Puma Biotechnology Inc CEO Alan Auerbach Sells 41,396 Shares (GuruFocus.com)
Dec-11-23 08:30AM	Puma Biotechnology Announces Phase II Clinical Trial Design for Alisertib in HER2-Negative, Hormone Receptor-Positive Metastatic Breast Cancer (Business Wire) -7.99%
Nov-20-23 11:47AM	Here's Why You May Invest in Puma Biotechnology (PBYI) Stock (Zacks)
Nov-06-23 05:15PM	Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Nov-03-23 12:16PM	Puma Biotech (PBYI) Q3 Earnings Beat, Revenues Lag Estimates (Zacks) +11.65%
09:34AM	Q3 2023 Puma Biotechnology Inc Earnings Call (Thomson Reuters StreetEvents)
09:31AM	Puma Biotechnology, Inc. (NASDAQ:PBYI) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-02-23 07:42PM	Puma Biotechnology Inc (PBYI) Reports Positive Net Income and Cash Flow in Q3 2023 (GuruFocus.com) -6.04%
04:47PM	Puma Biotech: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Puma Biotechnology Reports Third Quarter 2023 Financial Results (Business Wire)
Oct-19-23 04:14PM	Puma Biotechnology to Host Conference Call to Discuss Third Quarter 2023 Financial Results (Business Wire)
Oct-14-23 12:30PM	Puma Biotechnology Announces Presentation of Findings from a Phase I/II Study of Alisertib and Pembrolizumab for Rb-Deficient Head and Neck Squamous Cell Carcinomas at the 2023 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Meeting (Business Wire)
Oct-04-23 05:30PM	Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Sep-22-23 07:57AM	Puma's (PBYI) Alisertib Gets FDA's Orphan Drug Tag for SCLC (Zacks)
Sep-21-23 04:10PM	Puma Biotechnology Receives FDA Orphan Drug Designation for Alisertib for the Treatment of Small Cell Lung Cancer (Business Wire)
Aug-31-23 04:07PM	Puma Biotechnology to Present at the H.C. Wainwright 25th Annual Global Investment Conference (Business Wire)
Aug-08-23 08:30AM	Puma Biotechnology Announces FDA Clearance of IND for Alisertib in Small Cell Lung Cancer (Business Wire)
Aug-04-23 12:36PM	Puma Biotech (PBYI) Q2 Earnings Beat, Nerlynx Sales Outperform (Zacks) +8.52%
09:23AM	Q2 2023 Puma Biotechnology Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-03-23 05:17PM	Puma Biotech: Q2 Earnings Snapshot (AP Finance)
04:05PM	Puma Biotechnology Reports Second Quarter Financial Results (Business Wire)
Jul-20-23 04:15PM	Puma Biotechnology to Host Conference Call to Discuss Second Quarter 2023 Financial Results (Business Wire)
Jun-13-23 09:30AM	5 Biotech Stocks to Buy as Industry Prospects for 2H23 Look Good (Zacks)
Jun-06-23 05:03PM	Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Jun-04-23 09:00AM	Puma Biotechnology Announces Presentation of Biomarker Findings from a Phase II Study of Alisertib with Paclitaxel versus Paclitaxel Alone in Metastatic or Locally Recurrent Breast Cancer at the 2023 ASCO Annual Meeting (Business Wire)
May-28-23 10:06AM	Should You Be Concerned About Puma Biotechnology, Inc.'s (NASDAQ:PBYI) ROE? (Simply Wall St.)
May-22-23 11:07AM	Reasons to Add Puma (PBYI) Stock to Your Portfolio Right Now (Zacks) +5.54%
May-05-23 05:15PM	Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) +20.69%
12:45PM	Puma Biotech (PBYI) Q1 Earnings Beat, Nerlynx Sales Rise Y/Y (Zacks)
09:44AM	Q1 2023 Puma Biotechnology Inc Earnings Call (Thomson Reuters StreetEvents)
May-04-23 05:32PM	Puma Biotech: Q1 Earnings Snapshot (AP Finance)
04:04PM	Puma Biotechnology Reports First Quarter Financial Results (Business Wire)
Apr-20-23 04:15PM	Puma Biotechnology to Host Conference Call to Discuss First Quarter 2023 Financial Results (Business Wire)
Apr-17-23 06:49AM	Puma Biotechnology, Inc. (NASDAQ:PBYI) Held Back By Insufficient Growth Even After Shares Climb 34% (Simply Wall St.)
Apr-11-23 05:15PM	Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Mar-14-23 08:30AM	Puma Biotechnology Announces Publication of Phase II Clinical Trial of Alisertib in JAMA Oncology (Business Wire)
Mar-06-23 09:48AM	Puma Biotechnology, Inc. (NASDAQ:PBYI) Q4 2022 Earnings Call Transcript (Insider Monkey) -6.23%
Mar-03-23 05:15PM	Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) -19.35%
02:20PM	Puma Biotech (PBYI) Q4 Loss Wider Than Expected, Sales Top (Zacks)
06:22AM	Q4 2022 Puma Biotechnology Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-02-23 04:05PM	Puma Biotechnology Reports Fourth Quarter and Full Year Financial Results (Business Wire)
Feb-28-23 04:15PM	Puma Biotechnology to Participate in a Panel Discussion at Cowens 43rd Annual Health Care Conference (Business Wire)
Feb-19-23 02:05PM	7 A-Rated Penny Stocks Worth Betting On (InvestorPlace)
Feb-16-23 04:31PM	Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2022 Financial Results (Business Wire)
Feb-07-23 05:30PM	Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) +5.31%

Puma Biotechnology, Inc. is a biopharmaceutical company. It acquires and develops innovative products for the treatment of various forms of cancer. It focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seek to further develop those drug candidates for commercial use. The company was founded by Alan H. Auerbach on September 15, 2010 and is headquartered in Los Angeles, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
MILLER MICHAEL PATRICK	Director	Aug 12 '24	Sale	3.49	23,358	81,466	47,000	Aug 13 09:09 PM
MILLER MICHAEL PATRICK	Director	Aug 12 '24	Proposed Sale	3.76	23,358	87,826		Aug 12 09:27 PM
NOUGUES MAXIMO F	Chief Financial Officer	Jul 17 '24	Sale	3.70	4,156	15,382	162,522	Jul 18 07:11 PM
Ludwig Jeffrey Jerome	Chief Commercial Officer	Jul 17 '24	Sale	3.70	2,598	9,615	118,388	Jul 18 07:06 PM
HUNT DOUGLAS M	See Remarks	Jul 17 '24	Sale	3.70	3,637	13,461	133,227	Jul 18 06:57 PM
AUERBACH ALAN H	President and CEO	Jul 17 '24	Sale	3.70	21,920	81,128	7,063,515	Jul 18 06:50 PM
NOUGUES MAXIMO F	Chief Financial Officer	Jul 02 '24	Sale	3.27	5,295	17,307	166,678	Jul 02 09:22 PM
Ludwig Jeffrey Jerome	Chief Commercial Officer	Jul 02 '24	Sale	3.27	6,051	19,778	120,986	Jul 02 09:19 PM
HUNT DOUGLAS M	See Remarks	Jul 02 '24	Sale	3.27	4,349	14,215	136,864	Jul 02 09:15 PM
AUERBACH ALAN H	President and CEO	Jul 02 '24	Sale	3.27	18,885	61,726	7,085,435	Jul 02 09:10 PM
WILSON TROY EDWARD	Director	Jun 13 '24	Sale	3.33	27,000	89,902	350	Jun 17 07:27 PM
Stuglik Brian M	Director	Jun 13 '24	Sale	3.39	9,900	33,528	49,058	Jun 17 07:25 PM
Senderowicz Adrian	Director	Jun 13 '24	Sale	3.33	27,000	89,818	0	Jun 17 07:23 PM
MOYES JAY M	Director	Jun 13 '24	Sale	3.34	22,000	73,467	21,322	Jun 17 07:21 PM
Dorval Allison	Director	Jun 13 '24	Sale	3.37	11,000	37,096	33,000	Jun 17 07:18 PM
Wong Alvin F	Chief Scientific Officer	Jan 03 '24	Sale	4.49	7,733	34,689	98,214	Jan 05 07:03 PM
Ludwig Jeffrey Jerome	Chief Commercial Officer	Jan 03 '24	Sale	4.49	12,956	58,119	99,970	Jan 05 07:00 PM
AUERBACH ALAN H	President and CEO	Jan 03 '24	Sale	4.49	41,396	185,698	6,936,947	Jan 05 06:56 PM
NOUGUES MAXIMO F	Chief Financial Officer	Jan 03 '24	Sale	4.49	15,682	70,348	128,666	Jan 05 06:49 PM
HUNT DOUGLAS M	See Remarks	Jan 03 '24	Sale	4.49	8,358	37,493	103,319	Jan 05 06:42 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PBYI

Puma Biotechnology Inc

Upgrade your FINVIZ experience